Each year, up to 40 percent of travelers worldwide are hit by a painful disorder in the digestive tract called traveler’s diarrhea.
The condition, which is defined by having three or more unformed stools in 24 hours, can derail your travel plans and leave you bedridden with nausea, abdominal cramps, and persistent vomiting.
Now, adult travelers have a new treatment option for when diarrhea strikes.
The FDA recently approved an antibacterial drug called Aemcolo (rifamycin) to relieve the uncomfortable symptoms caused by noninvasive Escherichia coli (E. coli) that do not involve bloody stools or fever.
The drug, which is to be taken orally, is expected to be available by February, the FDA stated.